デフォルト表紙
市場調査レポート
商品コード
1566203

透析の市場規模、シェア、成長分析、タイプ別、製品・サービス別、エンドユーザー別、地域別 - 産業予測、2024年~2031年

Dialysis Market Size, Share, Growth Analysis, By Type (Hemodialysis, Peritoneal Dialysis), By Products and Services (Equipment, Consumables), By End User (In-center Dialysis, Home Dialysis), By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
透析の市場規模、シェア、成長分析、タイプ別、製品・サービス別、エンドユーザー別、地域別 - 産業予測、2024年~2031年
出版日: 2024年10月01日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の透析の市場規模は、2022年に1,108億米ドルとなり、2023年の1,158億2,000万米ドルから、2031年までには1,624億5,000万米ドルに成長し、予測期間(2024年~2031年)のCAGRは4.32%で成長する見通しです。

透析市場は、慢性腎臓病の有病率の大幅な上昇により、腎クリニックでの治療を求める患者が増加しているため、力強い成長を遂げています。特に米国メディケア&メディケイドサービスセンター(CMS)を中心とする民間および政府機関による支払い政策の強化がこの傾向を支えています。例えば、2019年、CMSは約7,000の末期腎疾患(ESRD)プロバイダーに血液透析費用を賄うためにおよそ103億米ドルのメディケア償還金を割り当てました。このような財政的支援は、今後数年間の市場拡大に拍車をかけると予想されます。米国国立衛生研究所(NIH)によると、COVID患者の約5%が腎代替療法を必要としており、多くの重症患者が急性腎障害に苦しんでいます。このような緊急のニーズに応えるため、病院では腎治療機器の導入が進んでおり、市場の成長軌道をさらに後押ししています。その結果、米国市場情勢は持続的な成長が見込まれ、今後の予測期間においても安定したCAGRを達成すると予測されています。これは、差し迫った医療需要と腎臓関連疾患の治療状況の進化を反映しています。

目次

イントロダクション

  • 調査の目的
  • 定義
  • 市場範囲

調査手法

  • 情報調達
  • 二次・一次情報源
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 市場概要見通し
  • 供給需要動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主要な市場の考察

  • 主要な成功要因
  • 競合の程度
  • 主要な投資機会
  • 市場のエコシステム
  • 特許分析
  • 技術分析
  • 規制情勢

透析市場:タイプ別

  • 市場概要
  • 血液透析
    • 従来の血液透析
    • 短期透析
    • 夜間血液透析
  • 腹膜透析
    • 持続携帯型腹膜透析(CAPD)透析
    • 自動腹膜透析(APD)

透析市場:製品・サービス別

  • 市場概要
  • サービス
  • 装置
    • 透析装置
    • 水治療システム
    • その他
  • 消耗品
    • 透析装置
    • カテーテル
    • その他
  • 透析薬剤

透析市場:エンドユーザー別

  • 市場概要
  • センター内透析
  • 在宅透析

透析市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主要な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Company
  • DaVita Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • JMS Co. Ltd.
  • Medtronic plc
  • Nikkiso Co. Ltd.
  • NIPRO Corporation
  • Satellite Healthcare Inc.
  • Toray Industries Inc.
  • Diaverum Deutschland GmbH
  • NxStage Medical, Inc.
  • Rockwell Medical Technologies, Inc.
  • AllMed Medical GmbH
  • Fresenius Kabi AG
  • Quanta Dialysis Technologies Ltd.
  • Outset Medical, Inc.
  • Medica S.p.A
目次
Product Code: SQSG35A2061

Global Dialysis Market size was valued at USD 110.80 billion in 2022 and is poised to grow from USD 115.82 billion in 2023 to USD 162.45 billion by 2031, growing at a CAGR of 4.32% during the forecast period (2024-2031).

The dialysis market is experiencing robust growth due to a significant rise in chronic kidney disease prevalence, leading to more patients seeking treatment at renal clinics. Enhanced payment policies from commercial and government entities, particularly the Centers for Medicare & Medicaid Services (CMS), support this trend; for instance, in 2019, CMS allocated roughly US$ 10.3 billion in Medicare reimbursements to around 7,000 end-stage renal disease (ESRD) providers to cover hemodialysis costs. This financial backing is expected to fuel market expansion in the coming years. Additionally, the recent COVID-19 pandemic has exacerbated the demand for renal equipment, as many critically ill patients suffer from acute kidney injury, with about 5% of COVID cases requiring renal replacement therapy according to the National Institutes of Health (NIH). Hospitals are increasingly adopting renal therapy equipment to meet this urgent need, further driving the market's growth trajectory. As a result, the US dialysis market is positioned for sustained growth, projected to achieve a consistent compound annual growth rate (CAGR) in the upcoming forecast period, reflecting both the pressing healthcare demands and the evolving treatment landscape for kidney-related disorders.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dialysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dialysis Market Segmental Analysis

Global Dialysis Market is segmented by Type, Products and Services, End User, and Region. Based on Type, the market is segmented into Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis), Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)). Based on Products and Services, the market is segmented into Services, Equipment (Dialysis Machines, Water Treatment Systems, Others), Consumables (Dialyzers, Catheters, Others), Dialysis Drugs. Based on End User, the market is segmented into In-center Dialysis, Home Dialysis. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dialysis Market

The escalating prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) is a significant market driver for the global dialysis market. As the burden of ESRD increases, necessitating long-term renal therapies or transplants, healthcare systems face immense financial pressures, thereby escalating the demand for efficient dialysis services. With approximately 15% of the U.S. population affected by CKD, the urgency for accessible renal care is heightened. Additionally, the expansion of nephrology specialists and renal care facilities in developed nations, coupled with investments aimed at establishing dialysis centers in emerging markets like India and China, underscores a robust growth trajectory. This demand for affordable yet effective renal treatments is projected to fuel substantial market revenue generation, making it a pivotal factor in the global dialysis landscape.

Restraints in the Global Dialysis Market

The global dialysis market faces significant restraint due to the growing preference for kidney transplantation as a treatment for end-stage renal disease (ESRD) and stage III chronic kidney disease (CKD). Patients often opt for transplantation over dialysis, attracted by the potential for better long-term outcomes and improved quality of life. Favorable reimbursement policies make kidney transplantation a more financially viable option, further driving this shift. Additionally, the rising costs associated with renal therapy, exacerbated by the coronavirus pandemic-especially in countries like India-may deter patients from opting for dialysis, ultimately hindering market growth and adoption of dialysis treatments.

Market Trends of the Global Dialysis Market

The Global Dialysis market is witnessing a significant trend of transitioning from traditional clinic-based care to homecare settings, driven by patient preferences, especially in developed economies. This shift is complemented by government initiatives, particularly in the United States, aimed at promoting cost-effective home treatment options for end-stage renal disease (ESRD). The emergence of advanced renal care technologies, including innovative dialysis machines and efficient dialyzers, is further propelling market growth, with key players like B.Braun and Fresenius Kabi leading the charge in product development. The focus on enhancing accessibility to homecare is expected to attract a growing number of patients seeking convenient and personalized treatment options, heralding a transformative phase in the dialysis landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Types
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Patent Analysis
  • Technology Analysis
  • Regulatory Landscape

Dialysis Market, By Type

  • Market Overview
  • Hemodialysis
    • Conventional Hemodialysis
    • Short Daily Hemodialysis
    • Nocturnal Hemodialysis
  • Peritoneal Dialysis
    • Continuous Ambulatory Peritoneal Dialysis (CAPD)
    • Automated Peritoneal Dialysis (APD)

Dialysis Market, By Products and Services

  • Market Overview
  • Services
  • Equipment
    • Dialysis Machines
    • Water Treatment Systems
    • Others
  • Consumables
    • Dialyzers
    • Catheters
    • Others
  • Dialysis Drugs

Dialysis Market, By End User

  • Market Overview
  • In-center Dialysis
  • Home Dialysis

Dialysis Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Asahi Kasei Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton Dickinson and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DaVita Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Medical Care AG & Co. KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • JMS Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nikkiso Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NIPRO Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Satellite Healthcare Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Toray Industries Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Diaverum Deutschland GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NxStage Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rockwell Medical Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AllMed Medical GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Kabi AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quanta Dialysis Technologies Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Outset Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medica S.p.A
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments